Ex parte CULLEN - Page 5




          Appeal No. 1999-2348                                                        
          Application No. 08/586,716                                                  


          forward then shifts to the applicant to overcome the prima                  
          facie case                                                                  
          with argument and/or evidence.  Obviousness is then determined              
          on                                                                          
          the basis of the evidence as a whole and the relative                       
          persuasiveness of the arguments.  See In re Oetiker, 977 F.2d               
          1443, 1445, 24 USPQ2d 1443, 1444 (Fed. Cir. 1992); In re                    
          Hedges, 783 F.2d 1038, 1039, 228 USPQ 685, 686 (Fed. Cir.                   
          1986); In re Piasecki, 745 F.2d 1468, 1472, 223 USPQ 785, 788               
          (Fed. Cir. 1984); and In re Rinehart, 531 F.2d 1048, 1052, 189              
          USPQ 143,  147 (CCPA 1976).  We are further guided by the                   
          precedent of our                                                            
          reviewing court that the limitations from the disclosure are                
          not to be imported into the claims.  In re Lundberg, 244 F.2d               
          543, 113 USPQ 530 (CCPA 1957); In re Queener, 796 F.2d 461,                 
          230 USPQ 438 (Fed. Cir. 1986).  We also note that the                       
          arguments not made separately for any individual claim or                   
          claims are considered waived.  See 37 CFR § 1.192(a) and (c).               
          In re Baxter Travenol Labs., 952 F.2d 388, 391, 21 USPQ2d                   
          1281, 1285 (Fed. Cir. 1991) ("It is not the function of this                
          court to examine the claims in greater detail than argued by                
                                          5                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007